Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

Adults with stage IB-IIIA resectable NSCLC received three cycles of nivolumab once every two weeks plus one cycle of ipilimumab or three cycles of chemotherapy followed by surgery.